Anatara Lifesciences Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anatara Lifesciences Ltd with three other
companies in this sector in AUSTRALIA :
Recce Pharmaceuticals Ltd
(2019
sales of 686,622.00 Australian Dollars [US$529,392.43 ]
),
Cann Global Ltd
(603,932.00 Australian Dollars [US$465,637.61 ]
), and
MGC Pharmaceuticals Ltd
(858,087.00 Australian Dollars [US$661,593.66 ]
).
Sales Analysis.
During the year ended June of 2019, sales at
Anatara Lifesciences Ltd were A$663,405.00 (US$511.49 thousand).
This
is
an
increase of 64.9%
versus 2018, when the company's sales were A$402,355.00 .
Despite this increase, sales are still
well
below the level achieved in 2017, when Anatara Lifesciences Ltd
reported sales of A$3.15 million.